News

Industry consortium sponsors study that substantiates its claim of better patient safety with more labeling

Near-total overlap of memberships, plus the rising importance of specialty pharma to all pharma distribution, seem to be the drivers

Per-product spending can top $2.5 million, finds Cutting Edge Information

Majority of top 20 companies to experience growth in sales

Zipnosis bypasses doctor’s visit, health insurance hassles for common ailments

Biggest barriers to RFID adoption include cost and uncertainty of ROI

Principles are response to new data showing counterfeiting on the rise

India and Thailand say WHO is confusing counterfeit issue with patent protection

Open house at newly built Louisville, KY logistics center launches the service

50 Years of Birth Control: Pharma Continues to Push for More Reproductive-Health Options

Some healthcare providers are pushing for OTC access to birth control. Pharma appears to be on the sideline in the debate

The growing number of states with laws now are joined by the “51st state”: the federal government

The types of delivery mechanisms that vary the uptake of a drug are multiplying

Consulting and marketing research firm breaks down product brand identity

Generics are now 75% of dispensed prescriptions, with generics up 5.9% in 2009 and branded products down 7.6%

Pedigree-pioneering team resurfaces with cloud-based collaborative platform

The biopharma company’s annual report provides clarity to a confusing marketplace

Faced with fierce competition, dwindling budgets and intense pressure to create jobs, economic development authorities are reinventing their recruitment strategies to attract life sciences employers

18th Annual Healthcare Compliance Packaging Council meeting celebrates the benefits of unit-dose packaging

Following are excerpts from the keynote presentation of Steven C. Anderson, president and CEO of the National Assn. of Chain Drug Stores, at its annual meeting, Palm Beach, FL, Apr. 25.

‘Revenue Management’ Comes to the Rescue of Pharma’s Complex Pricing Environment

The Medicines Company among first customers using 3PL Bridge to Europe program

Faster-than-average growth of biologics, more global trade to emerging countries, and widening regulatory requirements will propel the activity

Longitudinal patient-level data answer pressing questions about patient safety, outcomes and medication acceptance

Corporate culture rated as an important risk-assessment factor in Best Practices survey

Cegedim Dendrite 2010 Aggregate Spend Survey finds only 29% of companies confident in current reporting practices

[email protected] is to be a destination for healthcare provider complaints about drug promotion